Physician Profile

Upendra P. Hegde, M.D.

Associate Professor, Department of Medicine
Chief Medical Oncologist, Melanoma and Cutaneous Oncology; and Head and Neck Cancer/Oral Oncology
Office Locations:

Neag Comprehensive Cancer Center
UConn Health
Outpatient Pavilion, 4th Floor
263 Farmington Avenue
Farmington, CT 06030

Board Certifications:
  • Internal Medicine
  • Hematology
  • Medical Oncology
Education and Training:
Medical SchoolGoa Medical CollegeMedicine, Surgery
Medical SchoolGoa Medical CollegeGeneral Medicine
ResidencyGoa Medical College and HospitalCompulsory Rotatory
ResidencyGoa Medical College and HospitalPsychiatry and Human Behavior
ResidencyGoa Medical College and HospitalInternal Medicine
ResidencyGoa Medical College and HospitalInternal Medicine
FellowshipTata Memorial Cancer HospitalHematology/Oncology
FellowshipTata Memorial HospitalHematology/Oncology
OtherRush University Cancer Institute
ResidencyCook County HospitalInternal Medicine
FellowshipNational Heart, Lung and Blood InstituteHematology and Medical Oncology
Honors and Awards:
Name of Award/HonorAwarding Organization
America’s Best DoctorU.S. Public News
Named Top Doctor, Connecticut Magazine Survey of Connecticut Doctors Connecticut Magazine
Best Teaching Award, Hematology/Oncology Training Program, 2008-2009 UConn Health Center
PAWS Team Award, UConn Health CenterUConn Health Center Cares Council
Recipient of Scholarship Towards ASCO/AACR Workshop
Humanitarian Resident AwardCook County Hospital
Humanitarian Resident Award, Chicago, Illinois, 1996-1997 Cook County Hospital
USMLE 1, 2, 3
J.N. Tata Endowment Travel Scholarship
Research Scholarship, Chicago, Illinois, 1992-1995 Rush University Cancer Institute
Khandelwal Junior Oncology Award, Madras, India Indian Society of Oncology
Hospital Affiliation:
  • UConn John Dempsey Hospital
Selected Publications:

Peer Reviewed Publications

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Goldberg, Sarah B; Gettinger, Scott N; Mahajan, Amit; Chiang, Anne C; Herbst, Roy S; Sznol, Mario; Tsiouris, Apostolos John; Cohen, Justine; Vortmeyer, Alexander; Jilaveanu, Lucia; Yu, James; Hegde, Upendra; Speaker, Stephanie; Madura, Matthew; Ralabate, Amanda; Rivera, Angel; Rowen, Elin; Gerrish, Heather; Yao, Xiaopan; Chiang, Veronica; Kluger, Harriet M. (2016). The Lancet. Oncology,

Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer. Lalla, Rajesh V; Choquette, Linda E; Curley, Kathleen F; Dowsett, Robert J; Feinn, Richard S; Hegde, Upendra P; Pilbeam, Carol C; Salner, Andrew L; Sonis, Stephen T; Peterson, Douglas E. (2014). Oral oncology, 11, (50), 1098-103.

Durable spontaneous regression of lung metastases from renal cell carcinoma after incomplete use of multiple kinase inhibitor sorafenib. Hegde, Upendra; Patel, Vatsal; Kaloudis, Electra. (2013). International journal of urology : official journal of the Japanese Urological Association, 6, (20), 644-5.

Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly. Chakraborty, Nitya G; Yadav, Meeta; Dadras, Soheil S; Singh, Prashant; Chhabra, Arvind; Feinn, Richard; Kerr, Phillip E; Grant-Kels, Jane M; Mukherji, Bijay; Hegde, Upendra P. (2013). Human immunology, 5, (74), 640-7.

Metastatic melanoma in the older patient: special considerations. Hegde, Upendra P; Grant-Kels, Jane M. (2013). Clinics in dermatology, 3, (31), 311-6.